VENOM:
THE SYMBIOTE
MARKET REPORT

SECTION 1: THE ORIGIN STORY THAT BUILT A MARKET

Venom's trading card history begins not in 1988, but in 1984 — four years before Eddie Brock ever appeared. The black symbiote costume debuted in Marvel Super Heroes Secret Wars #8 (December 1984), and the 1984 Leaf Marvel Secret Wars sticker set captured that moment. Collectors who understand this distinction have a significant edge: the symbiote's card history predates Venom himself by nearly half a decade.

The first true Venom trading card came in the 1990 Impel Marvel Universe set — card #73, part of the Super Villains subset. That card, featuring Todd McFarlane's iconic black-and-white design, is now one of the most actively traded cards from that era. Raw copies sell for $3–$8; PSA 10 copies have crossed $2,500 in recent auctions. The 1992 Impel Marvel Universe Series III added a Venom "battle card" that has become a grail piece in the hobby, with PSA 10 copies fetching $1,500–$2,500 depending on population reports.

"Venom is the only Marvel villain to headline three solo films and maintain a top-ten trading card market position for over three decades. That's not a trend. That's a franchise."

SECTION 2: THE KEY ISSUE ECOSYSTEM

Understanding Venom's card market requires understanding the key issue ecosystem that drives collector interest. Amazing Spider-Man #252 (May 1984) — first appearance of the black costume — is the gateway key, with CGC 9.4 copies trading at $350–$500. Amazing Spider-Man #300 (May 1988) — first full appearance of Venom — is the anchor key, with CGC 9.4 copies at $500–$700 and CGC 9.8 copies commanding $1,200–$1,800. Venom: Lethal Protector #1 (February 1993) — first solo series — is the sleeper key, with CGC 9.8 copies at $80–$120.

The correlation between key issue prices and trading card values is direct and measurable. When ASM #300 CGC 9.4 values spiked 40% in Q3 2021 (driven by the first Venom film's home release), Venom trading cards across all eras followed within 60 days. CBH Intelligence tracks this correlation as a leading indicator: when ASM #300 moves, Venom cards move.

SECTION 3: THE 2025 TOPPS CARD — WHAT YOU'RE ACTUALLY BUYING

Card #84 in the 2025 Topps Marvel Comic Book Heroes set places Venom in the 2000s era subset — a deliberate curatorial choice that acknowledges the character's peak cultural saturation during the early 2000s comic book boom. The card's design draws from the vintage 1975/1976 aesthetic: bold borders, halftone dot texture, and the kind of graphic simplicity that made the original Topps Marvel sets so visually distinctive.

The 2025 card is Venom's first appearance in a Topps-licensed Marvel set since the 1990s. That gap matters. Collectors who built their Venom card collections during the Impel and SkyBox era now have a new anchor point, and the 2025 card's position in the 2000s subset creates a natural narrative bridge between the character's comic book origins and his modern MCU-adjacent status.

SECTION 4: THE MCU WILDCARD

The single most important variable in Venom's card market is MCU integration. Tom Hardy's Sony trilogy — Venom (2018), Venom: Let There Be Carnage (2021), Venom: The Last Dance (2024) — generated massive box office revenue but existed in a licensing gray zone that kept the character out of the main MCU timeline. The post-credits scene in No Way Home suggested integration was coming; The Last Dance's ending left the door open.

When Venom formally enters the MCU — whether through a new actor or a continuation of Hardy's portrayal — the card market will react immediately. CBH Intelligence estimates a 40–60% value increase for base PSA 10 copies within 90 days of a confirmed MCU Venom announcement. Collectors who position themselves before that announcement will capture the full appreciation. Those who wait for confirmation will pay a premium.